TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06535555

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Investigational Safety and Feasibility
Description: Technical feasibility will be assessed based on a five-point rating scale assessing the ease-of-use, ureteral visibility, and time required to identify the ureter using ActivSight™. All images and video of the ureter will be recorded, but surgeon feedback will be used to assess technical success based on a five point scale, rather than these (subsequently de-identified) recordings.~Safety will be confirmed through clinical assessments and evaluation of adverse events intraoperatively and through a 28-day follow-up period using the criteria listed below. All adverse events will be adjudicated by the site's Principal Investigator (PI) to judge the relatedness of the adverse event to either the administration of riboflavin or the use of the prototype ActivSight™ device (or whether the adverse event was unrelated to either)
Study: NCT05429489

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilevel erector spinae plane block
Description: Bilevel erector spinae plane block at 3rd and 5th thoracic vertebral levels

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single level erector spinae plane block
Description: Single level erector spinae plane block at 5th thoracic vertebrae

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous morphine
Description: Intravenous morphine 0.1 mg/kg
Study: NCT06118229

Intervention type: DEVICE
Intervention: Wearable smart devices and PROs
Description: Patients wearing wearable smart devices to monitor physiological data while regularly utilizing PROs to report subjective assessments of their own health status.
Study: NCT04922216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simplified Diet Monitoring
Description: Simplified diet monitoring using smartphone tracking of red foods using a traffic light approach.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.
Study: NCT05114109

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isatuximab Injection
Description: Isatuximab will be given intravenously at 10mg/kg at day 0, week (W)1, W2, W3, and W4 then every 2 weeks for a total of 12 infusions.
Study: NCT04922216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.
Study: NCT04820101

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: administrating dexmedetomidine in order to evaluate the efficacy in achieving sedation for LISA procedure
Study: NCT04922216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.
Study: NCT05753644

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: stellate ganglion blocks
Description: At the level between C6 and C7, a 25-gauge needle is inserted laterally, and the needle tip is placed posterior to the carotid artery and anterior to the longus colli muscle using an in-plane approach.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: stellate ganglion blocks
Description: At the level between C6 and C7, a 25-gauge needle is inserted laterally, and the needle tip is placed posterior to the carotid artery and anterior to the longus colli muscle using an in-plane approach.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Description: 5 mL of 0.5% ropivacaine injected in the plane of the right stellate ganglion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sham treatment
Description: 5 mL of saline injected in the plane of the right stellate ganglion
Study: NCT05333887

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PFC+
Description: Therapists instruct parents in ways to coach their children to display better friendship behaviours using skill teaching and home practice. The program includes 2 intake sessions, a group workshop where all strategies are reviewed, and 3 consultation sessions to work on implementing strategies with therapist support. Emphasis throughout the program is placed on parents' connection and engagement with the material and therapist.
Study: NCT06064032

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: cognitive behavioral therapy
Description: In control group there is 10 min session of PMR, 2 min deep breathing exercises,3 min training for life style modification which include use of planner, setting alarms breaking a task into parts positive reinforcement and communication.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive behavioral therapy
Description: In control group there is 10 min session of PMR, 2 min deep breathing exercises,3 min training for life style modification which include use of planner, setting alarms breaking a task into parts positive reinforcement and communication.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motor Learning Techniques
Description: In experimental group, participants will be given a 10 min PMR ,2 min deep breathing exercises, 3 min training for life style modification which include the use of planners setting alarms, breaking a difficult task into parts, positive reinforcement and communication combined with 3 min session of drawing a specific pattern with installing pegs on pegboard, 2 min session of balance board training, 3 min session of jigsaw puzzle training, 1 min session of squeezing a ball with maximum repetition and 1 min session of finding beads in puttey.
Study: NCT05771090

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sokru device
Description: Different induced glycaemic states in people living with diabetes (PwD).
Study: NCT04993963

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cycle Ergometery Training (Prehabilitation)
Description: Interval training on cycle ergometer: between 40% and 60% Vo2max, perceived exertion \<13 on Borg scale 20-30 min/session/day (intermittent of exercise 2-3 mint, followed by 1-2 min of active recovery) Cool down (5 minutes) AROM +Body stretch

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Standard Group
Description: Breathing exercise 15 Reps and Walk (10-15 minutes)
Study: NCT06453902

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TGRX-678
Description: All patients will be given TGRX-678 240 mg once daily. TGRX-678 is to be taken orally
Study: NCT04922216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Daily)
Description: Physical activity goals that adapt once each day using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Weekly)
Description: Physical activity goals that adapt once each week using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Weekly)
Description: Physical activity goals that adapt once each week using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Weekly)
Description: Physical activity goals that adapt once each week using the participants' data derived from activity tracker.
Study: NCT06204796

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: vitamin D supplement was given as 60,000 IU weekly in conjunction with systemic prednisone
Description: All participants received 40-60 mg of systemic prednisone as a single morning dose according to the severity of the condition until a 50% reduction in lesion size was achieved then the dose was tapered by 10mg each week and finally to 5 mg/day for the last week. Patients were followed up weekly for up to 60 days. The length and dose of treatment were adjusted according to clinical needs in each case. In addition, a vitamin D supplement was given as 60,000 IU weekly in conjunction with systemic steroids.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic prednisone
Description: All participants received 40-60 mg of systemic prednisone as a single morning dose according to the severity of the condition until a 50% reduction in lesion size was achieved then the dose was tapered by 10mg each week and finally to 5 mg/day for the last week. Patients were followed up weekly for up to 60 days. The length and dose of treatment were adjusted according to clinical needs in each case.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic prednisone
Description: All participants received 40-60 mg of systemic prednisone as a single morning dose according to the severity of the condition until a 50% reduction in lesion size was achieved then the dose was tapered by 10mg each week and finally to 5 mg/day for the last week. Patients were followed up weekly for up to 60 days. The length and dose of treatment were adjusted according to clinical needs in each case.
Study: NCT04922216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Weekly)
Description: Physical activity goals that adapt once each week using the participants' data derived from activity tracker.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Weekly)
Description: Physical activity goals that adapt once each week using the participants' data derived from activity tracker.
Study: NCT06234865

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Patients in the control group will receive standard education plus a brochure education. Standard education includes education provided by the doctor, nurse and/or physiotherapist before and after surgery. The brochure education includes information about constipation and interventions that can be used to prevent constipation such as nutrition, fluid intake, physical activity, leg exercises, abdominal massage, and toilet habits.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video Education Group
Description: Patients in the experimental group will receive standard education plus a video education. Standard education includes education provided by the doctor, nurse and/or physiotherapist before and after surgery. The video education includes information about constipation and interventions that can be used to prevent constipation such as nutrition, fluid intake, physical activity, leg exercises, abdominal massage, and toilet habits.
Study: NCT05819190

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Healsea Rescue*
Description: Subjects will be administered with Healsea Rescue\* by spraying 2 puffs in each nostril 2 times per day during 7 days.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will be administered with isotonic saline nasal spray indistinguishable from the Healsea Rescue\* by spraying 2 puffs in each nostril 2 times per day during 7 days.
Study: NCT05302791

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Muscle Cooling
Description: Cooling wrap will be set to 10°C

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Resistance Exercise
Description: Resistance Machines (Leg Press and Knee extension). 12 rep Max

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance Exercise
Description: Resistance Machines (Leg Press and Knee extension). 12 rep Max
Study: NCT04495634

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stationary Head CT (s-HCT)
Description: The system consists of a total of three x-ray sources and nine x-ray detectors with an estimation of approximately 150 projection angles per slice, with less than a minute per slice reconstruction. Radiation dose will be configured as to not exceed that of a conventional head CT, or 2 mSv. The subjects will be positioned on a medical procedure table that will move the subject through the scanning system at the rate of roughly 1 cm per second, during which the necessary x-ray projections will be acquired. The head will be positioned in a carbon fiber head holder from a clinical CT scanner that is secured to the table.
Study: NCT04922216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adaptive Activity Goals (Weekly)
Description: Physical activity goals that adapt once each week using the participants' data derived from activity tracker.
Study: NCT04853576

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: EDIT-301
Description: Administered by IV infusion after myeloablative conditioning with busulfan.
Study: NCT04518930

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peanuts or plain Greek yogurt
Description: Two different types of dietary snacks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peanuts or plain Greek yogurt
Description: Two different types of dietary snacks
Study: NCT05133362

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Gait training with EksoNR
Description: Participants will receive forward gait training with EksoNR

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gait training with EksoNR
Description: Participants will receive forward gait training with EksoNR

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Backward gait training with EksoNR
Description: Participants will receive backward gait training with EksoNR
Study: NCT05457361

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VEN combined with azacitidine plus homoharringtonine
Description: VEN begins at 100 mg on day 1 and increases stepwise over 3 days to reach the target dose of 400 mg (100 mg, 200 mg, 400 mg); dosing is continued at 400 mg per day from day 4 through day 14; azacitidine (75 mg/m²) is administered subcutaneously on days 1-7, and HHT (1 mg/m²) on days 1-7.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: VEN combined with azacitidine
Description: The use of VEN is just the same as it dose in VAH regimen except lasting for 28 days. The use of azacitidine is exactly the same as VAH group does.
Study: NCT06123117

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: single transversus abdominis laparoscopy-guided plane block
Description: please see arm/group descriptions

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: single transversus abdominis laparoscopy-guided plane block
Description: please see arm/group descriptions

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: single transversus abdominis laparoscopy-guided plane block
Description: please see arm/group descriptions

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: local trocar site ropivacaine infiltration
Description: please see arm/group descriptions

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: local trocar site ropivacaine infiltration
Description: please see arm/group descriptions

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: local trocar site ropivacaine infiltration
Description: please see arm/group descriptions

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: local trocar site ropivacaine infiltration
Description: please see arm/group descriptions

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: local trocar site ropivacaine infiltration
Description: please see arm/group descriptions
Study: NCT06123117

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: local trocar site ropivacaine infiltration
Description: please see arm/group descriptions
Study: NCT06550115

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time-restricted eating
Description: Night shift workers will participate in 4 weeks of fasting during the biological nighttime while remaining awake during overnight work shifts.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control eating
Description: Night shift workers will participate in 4 weeks of Control eating across the daytime and nighttime hours while remaining awake during overnight work shifts.
Study: NCT04895566

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Monoclonal antibody (Mab) sB24M
Description: 200 mg monoclonal antibody (Mab) sB24 by injection into the affected areas.
Study: NCT04916275

Intervention type: OTHER
Intervention: Cognitive tests
Description: Optional tests: Corsi block-tapping task, Stroop test and Iowa gambling task
Study: NCT05119660

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Theta Burst Stimulation
Description: iTBS

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Theta Burst Stimulation
Description: iTBS
Study: NCT06217354

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carbetocin 100 Microgram/mL Solution for Injection
Description: All patients will receive a bolus of carbetocin 100mcg IV over one minute after cord clamping. \[PabalVR, Ferring AG, Baar, Switzerland\]).then assess uterine contractility and postpartum bleeding measuring

Intervention type: DRUG
Group type: OTHER
Intervention: Carbetocin 100 Microgram/mL Solution for Injection
Description: All patients will receive a bolus of carbetocin 100mcg IV over one minute after cord clamping. \[PabalVR, Ferring AG, Baar, Switzerland\]).then assess uterine contractility and postpartum bleeding measuring
Study: NCT05216237

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab 200 mg, intravenously (IV) every 3 weeks(Q3W)
Description: for 2-6 cycles followed by Sindilizumab plus Tegafur gimeracil oteracil potassium capsules.
Study: NCT05707052

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neck-Trunk Stabilization Exercises and conventional physical therapy
Description: Neck-Trunk Stabilization Exercises along with conventional physical therapy in which stretching, strengthening, ROMs positioning and electrical stimulation are included.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bobath Therapy and conventional physical therapy
Description: Bobath based exercises along with conventional physical therapy in which stretching, strengthening, ROMs positioning and electrical stimulation are included.
Study: NCT05649098

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab
Description: The treatment period will include a 16-week open-label phase and a 20-month long-term extension phase for those who qualify and wish to continue.
Study: NCT05689216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Awake timed prone and repositioning
Description: Patients were instructed to adopt a timed prone and repositioning strategy with 4 sessions for four consecutive days.~Session 1, lying on the belly; Session 2, lying on the right side; Session 3, sitting up; Session 4, lying on the left side; then back to session 1 (30 minutes to two hours for each session). The daily duration of timed prone and repositioning is strongly recommended for 8-10 hours.
Study: NCT04467515

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAM-H2
Description: All patients will receive at least 1 cycle of CAM-H2. Patients with CB may receive 4 cycles of CAM-H2, each cycle given as 2 IV administrations, 4 weeks apart.
Study: NCT04887688

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: exciflex
Description: untethered electronic bandage with all the components of a surface stimulation system mounted on a flexible substrate.